Prab at 20:46, 16 March 2025

2025-03-16T20:46:25Z

← Older revision		Revision as of 20:46, 16 March 2025
Line 19:		Line 19:
	[[Category:Antineoplastic agents]]		[[Category:Antineoplastic agents]]
	{{cancer-stub}}		{{cancer-stub}}
	~~{{No image}}~~
	==Esperamicin==		==Esperamicin==
	<gallery>		<gallery>

Prab: CSV import

2025-02-24T23:49:29Z

CSV import

← Older revision		Revision as of 23:49, 24 February 2025
Line 20:		Line 20:
	{{cancer-stub}}		{{cancer-stub}}
	{{No image}}		{{No image}}
			==Esperamicin==
			<gallery>
			File:Esperamicin.png\|Esperamicin
			File:Esperamicin_A1_3D_spacefill.png\|Esperamicin A1 3D spacefill
			</gallery>

Prab: CSV import

2025-02-10T16:45:22Z

CSV import

← Older revision		Revision as of 16:45, 10 February 2025
Line 19:		Line 19:
	[[Category:Antineoplastic agents]]		[[Category:Antineoplastic agents]]
	{{cancer-stub}}		{{cancer-stub}}
			{{No image}}

Prab: CSV import

2024-03-26T20:34:36Z

CSV import

New page

'''Esperamicin''' is a class of [[antibiotics]] known for their potent [[antineoplastic]] (anti-cancer) properties. These compounds are [[enediynes]], a group of antibiotics that can bind to [[DNA]] and cause breaks in the DNA strands, leading to cell death. Esperamicins are particularly noted for their use in the development of [[Antibody-drug conjugates|antibody-drug conjugates (ADCs)]], which are designed to target cancer cells specifically, thereby minimizing damage to healthy cells.

==Discovery and Structure==
Esperamicins were first isolated from the [[Actinomycetes|actinomycete]] ''[[Micromonospora]]'' spp. These compounds are characterized by their enediyne core, a molecular structure that includes a double bond (ene) adjacent to a triple bond (diyne), which is crucial for their DNA-cleaving activity. The enediyne core is highly reactive and can generate a [[Biradical|biradical]] species under physiological conditions, leading to the abstraction of hydrogen atoms from DNA and subsequent strand scission.

==Mechanism of Action==
The mechanism of action of esperamicins involves the binding of the compound to the minor groove of DNA. Upon activation, typically by [[Thiol|thiol]] reduction, the enediyne core undergoes a Bergman cyclization to generate a diradical species. This diradical can abstract hydrogen atoms from the DNA backbone, resulting in double-strand breaks that ultimately lead to cell death. This mode of action is similar to other enediyne antibiotics, such as [[Calicheamicin]] and [[Neocarzinostatin]].

==Clinical Applications and Research==
Esperamicins have been extensively studied for their potential in cancer therapy, particularly in the development of ADCs. These conjugates aim to exploit the potent cytotoxicity of esperamicins by selectively delivering them to cancer cells, thus reducing the systemic toxicity associated with traditional chemotherapy. Research in this area focuses on identifying suitable [[Antibodies|antibodies]] that can target cancer-specific antigens and effectively deliver the esperamicin payload.

==Safety and Toxicity==
Due to their potent DNA-cleaving activity, esperamicins can be highly toxic, necessitating careful consideration in their therapeutic application. The development of ADCs seeks to mitigate this toxicity by ensuring that esperamicins are selectively delivered to cancer cells. However, the potential for off-target effects and damage to healthy cells remains a significant challenge in the clinical development of esperamicin-based therapies.

==Conclusion==
Esperamicins represent a powerful class of antineoplastic agents with significant potential for the treatment of cancer. Their mechanism of action, based on the unique enediyne core, allows for the efficient cleavage of DNA and the induction of cell death in targeted cancer cells. Ongoing research into the development of ADCs utilizing esperamicins highlights the continued interest in harnessing these compounds for cancer therapy, despite the challenges associated with their toxicity.

[[Category:Antibiotics]]
[[Category:Antineoplastic agents]]
{{cancer-stub}}

Esperamicin - Revision history

Prab at 20:46, 16 March 2025

Prab: CSV import

Prab: CSV import

Prab: CSV import